Download as PDF
PreveCeutical announces launch of new website and corporate logo
Vancouver, British Columbia, July 11, 2016 - PreveCeutical Medical Inc. ("PreveCeutical", or the "Company"), a health and wellness company focused on utilizing nature and science for the benefit of health-conscious consumers, is pleased to announce the launch of our new website and corporate logo. The website re-launch ensures that customers and interested parties can access the information they deem necessary to further research preventive health solutions while providing investors with all relevant documentation for the company as it moves closer to filing its application to list on the Canadian Securities Exchange.
The PreveCeutical website can be viewed at the following website: www.PreveCeutical.com.
“We are very excited to have the corporate logo launch and re-designed website finally available,” said Stephen Van Deventer, Chairman and CEO at PreveCeutical. “We are very thankful to everyone on the team that contributed, and the website re-launch aligns perfectly with the Company having CELLB9 available for sale, and the Company’s application to list on the CSE almost finalized and ready for submission. This will be a very exciting year for the Company and its shareholders.”
About PreveCeutical
PreveCeutical is a health and wellness Company focused on utilizing nature and science for the benefit of health conscious consumers. The Company recently announced CELLB9 being available for sale, where CELLB9 appears to be an immune system boosting dietary supplement derived from Blue Scorpion Venom.
For more information about PreveCeutical, please visit www.preveceutical.com, follow us on Twitter: https://twitter.com/preveceuticals, or on Facebook: www.facebook.com/Preveceutical.
On Behalf of the Board,
"Stephen Van Deventer"
Chairman & CEO
CAUTIONARY DISCLAIMER STATEMENT
The Company is not currently listed on the CSE or any stock exchange or quotation system. No stock exchange or securities regulatory authorized has reviewed or accepts responsibility for the adequacy or accuracy of the content of this news release. This news release is for information purposes only and should not be construed as a securities offering by the Company. .
This news release contains forward-looking statements, including without limitation, regarding the future operations of the Company and the healthcare industry. Forward-looking statements address future events and conditions and therefore involve inherent risks, uncertainties and assumptions. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future or future trends. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as “may”, “expect”, “estimate”, “will”, “anticipate”, “intend”, “believe” and “continue” or the negative thereof or similar variations. There can be no assurance that such forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the listing conditions of the CSE or the management’s decision to abandon such listing for any reason.
Actual results may differ materially from those currently anticipated in such statements and the Company undertakes no obligation to update such statements, except as required by law. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks. In particular, there is no guarantee that the Company will be able to list its Shares on the CSE, no guarantee that the trends identified in this news release will benefit the Company, and that Blue Scorpion Venom will effectively treat or cure or prevent any diseases. Accordingly, actual results may differ materially from those currently anticipated in such statements.
Readers are cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. The reader is cautioned not to place undue reliance on any forward-looking information. The Company has made numerous assumptions regarding, among other things: the effectiveness of its products; the demand for its products and the stability of economic and market conditions. Readers are cautioned that all forward-looking statements involve risks and uncertainties, including: that the Company may lose or abandon or may fail to receive necessary licenses and permits; labour disputes affecting the Company; the Company may not receive the necessary regulatory approvals for its products or the intended listing; the increase in cost estimates and the potential for unexpected costs and expenses; worsening of general economic and market conditions; market shifts may require a change in strategic focus; the Company may not be able to raise additional funds when necessary; litigation affecting the Company; and competition. Factors that could cause actual results to differ materially from those in forward-looking statements include continued availability or lack of availability of suitable capital and financing or capital and financing in general for the Company, and general economic, market or business conditions, consumer sentiment towards the Company’s products, competition, the failure of counterparties to perform their contractual obligations, and fees charged by service providers.
All forward-looking statements concerning the Company's future plans and operations, including management's assessment of the Company's operational expectations or beliefs, may be subject to certain assumptions, risks and uncertainties beyond the Company's control. Investors are cautioned that any such statements are not guarantees of future performance and that actual performance and financial results may differ materially from any estimates or projections. Accordingly, readers should not place undue reliance on forward-looking statements and information, which are qualified in their entirety by this cautionary statement. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.